Egyptian Drug Authority Warns of Misleading Ad for Unregistered Retatrutide Product

The Egyptian Drug Authority has warned about a misleading promotional advertisement for a product carrying the name Retatrutide, which is not registered with the authority.

The warning followed the detection of advertising material containing misleading claims about the product.

The authority’s alert identified both the promotional claims and the product’s lack of registration as concerns. The summary did not specify what claims the advertisement made.

No details were provided about who was responsible for the advertisement or where it appeared. The warning focused on the unregistered product being promoted under the Retatrutide name.